156 related articles for article (PubMed ID: 38036951)
1. Quality indicators in prolonged hemodialysis with regional citrate anticoagulation with the genius system: retrospective cohort of critical patients with acute kidney injury.
Vieira JAM; Reinheimer IC; Dos Santos AC; Halperin FK; Susin LA; Staub LP; Ribeiro RJE; da Silveira JB; Fontoura LF; de Souza DC; Nunes KP; de Souza VC; da Silva Selistre L; Poli-de-Figueiredo CE
BMC Nephrol; 2023 Nov; 24(1):353. PubMed ID: 38036951
[TBL] [Abstract][Full Text] [Related]
2. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
Finkel KW; Foringer JR
Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
[TBL] [Abstract][Full Text] [Related]
3. Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure.
Schneider M; Liefeldt L; Slowinski T; Peters H; Neumayer HH; Morgera S
Int J Artif Organs; 2008 Jan; 31(1):43-8. PubMed ID: 18286453
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Regional Anticoagulation with 4% Trisodium Citrate Versus Heparin in Extended Hemodialysis among Critical Patients with Cancer and Acute Kidney Injury.
Moura EIM; de Brito GA; Alves JA; Imanishe MH; Baptista AL; Andrade LAS; Pereira BJ
Blood Purif; 2021; 50(1):50-56. PubMed ID: 32388506
[TBL] [Abstract][Full Text] [Related]
5. A novel citrate-based protocol versus heparin anticoagulation for sustained low-efficiency dialysis in the ICU: safety, efficacy, and cost.
Wen M; Küchle C; Steubl D; Satanovskji R; Heemann U; Suttmann Y; Angermann S; Kemmner S; Rehbehn L; Huber M; Hauser C; Schmaderer C; Reichelt AL; Haller B; Renders L
BMC Nephrol; 2018 Apr; 19(1):79. PubMed ID: 29614970
[TBL] [Abstract][Full Text] [Related]
6. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
7. Sustained low-efficiency dialysis with regional citrate anticoagulation in critically ill patients with COVID-19 associated AKI: A pilot study.
Di Mario F; Regolisti G; Di Maria A; Parmigiani A; Benigno GD; Picetti E; Barbagallo M; Greco P; Maccari C; Fiaccadori E
J Crit Care; 2021 Jun; 63():22-25. PubMed ID: 33611151
[TBL] [Abstract][Full Text] [Related]
8. A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure.
Morgera S; Scholle C; Melzer C; Slowinski T; Liefeld L; Baumann G; Peters H; Neumayer HH
Nephron Clin Pract; 2004; 98(1):c35-40. PubMed ID: 15361702
[TBL] [Abstract][Full Text] [Related]
9. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience.
Morgera S; Scholle C; Voss G; Haase M; Vargas-Hein O; Krausch D; Melzer C; Rosseau S; Zuckermann-Becker H; Neumayer HH
Nephron Clin Pract; 2004; 97(4):c131-6. PubMed ID: 15331942
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
Arnold F; Westermann L; Rieg S; Neumann-Haefelin E; Biever PM; Walz G; Kalbhenn J; Tanriver Y
BMC Nephrol; 2020 Nov; 21(1):486. PubMed ID: 33198670
[TBL] [Abstract][Full Text] [Related]
11. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
Sık G; Demirbuga A; Annayev A; Citak A
Int J Artif Organs; 2020 Apr; 43(4):234-241. PubMed ID: 31856634
[TBL] [Abstract][Full Text] [Related]
12. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
[TBL] [Abstract][Full Text] [Related]
13. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
Gould DW; Doidge J; Sadique MZ; Borthwick M; Hatch R; Caskey FJ; Forni L; Lawrence RF; MacEwen C; Ostermann M; Mouncey PR; Harrison DA; Rowan KM; Young JD; Watkinson PJ
Health Technol Assess; 2022 Feb; 26(13):1-58. PubMed ID: 35212260
[TBL] [Abstract][Full Text] [Related]
14. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
Schilder L; Nurmohamed SA; Bosch FH; Purmer IM; den Boer SS; Kleppe CG; Vervloet MG; Beishuizen A; Girbes AR; Ter Wee PM; Groeneveld AB;
Crit Care; 2014 Aug; 18(4):472. PubMed ID: 25128022
[TBL] [Abstract][Full Text] [Related]
15. [The safety and efficacy of regional citrate anticoagulation in sustained low efficiency dialysis].
Zhang L; Wang TL; Zhao YL; Chen ZW; Tang Y; Yang YY; Liao YJ; Fu P
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):459-63. PubMed ID: 24059990
[TBL] [Abstract][Full Text] [Related]
16. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
[TBL] [Abstract][Full Text] [Related]
17. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.
Hetzel GR; Schmitz M; Wissing H; Ries W; Schott G; Heering PJ; Isgro F; Kribben A; Himmele R; Grabensee B; Rump LC
Nephrol Dial Transplant; 2011 Jan; 26(1):232-9. PubMed ID: 20876598
[TBL] [Abstract][Full Text] [Related]
18. Citrate anticoagulation in the ICU: the Leeds experience.
Trumper C
Br J Nurs; 2016 Sep; 25(16):902-6. PubMed ID: 27615524
[TBL] [Abstract][Full Text] [Related]
19. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
Wu MY; Hsu YH; Bai CH; Lin YF; Wu CH; Tam KW
Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
[TBL] [Abstract][Full Text] [Related]
20. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients.
Kutsogiannis DJ; Gibney RT; Stollery D; Gao J
Kidney Int; 2005 Jun; 67(6):2361-7. PubMed ID: 15882280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
